Precigen

Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing gene and cell therapies for immuno-oncology, autoimmune disorders, and infectious diseases. The company was founded in 1998 and is headquartered in Germantown, Maryland.